UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 97

Sortiert nach

How should we treat very high blood pressure until we distinguish between hypertensive emergency and urgency?

Hypertension research, 2020-05, Vol.43 (5), p.470-472

2020

Volltextzugriff (PDF)

Hypertensive emergency is characterized by acute hypertension-mediated organ damage but also a life-threatening status

Hypertension research, 2020-12, Vol.43 (12), p.1457-1458

2020

Volltextzugriff (PDF)

Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk

Journal of human hypertension, 2021-07, Vol.35 (7), p.564-576

2021

Volltextzugriff (PDF)

Beta blocker rebound phenomenon is important, but we do not know its definition, incidence or optimal prevention strategies

Hypertension research, 2020-07, Vol.43 (7), p.591-596

2020

Volltextzugriff (PDF)

Impending hypertensive emergency is frequently considered in guidelines, but neither defined nor explained

Blood pressure, 2020-09, Vol.29 (5), p.336-337

2020

Volltextzugriff (PDF)

Long-lasting, resistant hypertension should be a part of the aortic dissection risk score

Hypertension research, 2019-11, Vol.42 (11), p.1836-1838

2019

Volltextzugriff (PDF)

Diabetic Cardiomyopathy: Clinical and Metabolic Approach

Current vascular pharmacology, 2021-01, Vol.19 (5), p.487

2021

Volltextzugriff (PDF)

Compelling Indications Should be Listed for Individual Beta-Blockers (Due to Diversity), Not for the Whole Class

Current vascular pharmacology, 2021-01, Vol.19 (4), p.343

2021

Volltextzugriff (PDF)

Contraindications Differ Widely Among Beta Blockers and Ought to be Cited for an Individual Drug, Not for the Entire Class

Current pharmaceutical design, 2021-01, Vol.27 (40), p.4125

2021

Volltextzugriff (PDF)

Coronary Microvascular Dysfunction and Hypertension: A Bond More Important than We Think

Medicina (Kaunas, Lithuania), 2023-12, Vol.59 (12), p.2149

2023

Volltextzugriff (PDF)

The Mechanisms of Actions of Aldosterone and its Antagonists in Cardiovascular Disease

Current pharmaceutical design, 2018-01, Vol.24 (46), p.5491

2018

Volltextzugriff (PDF)

Electrocardiographic criteria which have the best prognostic significance in hypertensive patients with echocardiographic hypertrophy of left ventricle: 15‐year prospective study

Clinical cardiology (Mahwah, N.J.), 2020-09, Vol.43 (9), p.1017-1023

2020

Volltextzugriff (PDF)

Rationale to search for masked hypertension in severe Cushing's disease

Minerva medica, 2023-02, Vol.114 (1), p.91

2023

Volltextzugriff (PDF)

A Critical Approach of Guideline Therapeutic Recommendations for NAFLD

Current vascular pharmacology, 2018-05, Vol.16 (3), p.228

2018

Volltextzugriff (PDF)

Cardiac Magnetic Resonance in Hypertensive Heart Disease: Time for a New Chapter

Diagnostics (Basel), 2022-12, Vol.13 (1), p.137

2022

Volltextzugriff (PDF)

Exercise Capacity and Atrial Fibrillation Risk in Veterans

Mayo Clinic proceedings, 2016-05, Vol.91 (5), p.558-566

2016

Volltextzugriff (PDF)

Conservative versus aggressive blood pressure reduction: Do we have a winner?

European journal of internal medicine, 2022-07, Vol.101, p.39-40

2022

Volltextzugriff (PDF)

Non-pharmacological Modulation of the Autonomic Nervous System for Heart Failure Treatment: Where do We Stand?

Current vascular pharmacology, 2018-01, Vol.16 (1), p.30

2018

Volltextzugriff (PDF)

Sodium-glucose Cotransporter 2 Inhibitors: Potential Cardiovascular and Mortality Benefits

Cardiovascular & hematological disorders drug targets, 2018, Vol.18 (2), p.114

2018

Volltextzugriff (PDF)

Dihydropyridine calcium channel blocker should be mentioned for prevention of aortic consequences of arterial hypertension

Journal of hypertension, 2012-07, Vol.30 (7), p.1487-1487

2012

Volltextzugriff (PDF)

The pathophysiological basis of carotid baroreceptor stimulation for the treatment of resistant hypertension

Current vascular pharmacology, 2014-01, Vol.12 (1), p.16

2014

Volltextzugriff (PDF)

Significance of Beta-Blocker in Patients with Hypertensive Left Ventricular Hypertrophy and Myocardial Ischemia

Current vascular pharmacology, 2023-01, Vol.21 (2), p.81

2023

Volltextzugriff (PDF)

Early Left Ventricular Systolic and Diastolic Dysfunction in Patients with Newly Diagnosed Obstructive Sleep Apnoea and Normal Left Ventricular Ejection Fraction

TheScientificWorld, 2014-01, Vol.2014, p.898746-7

2014

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(74)

Publikationsform

Artikel
(94)
Buchkapitel
(3)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

How should we treat very high blood pressure until we distinguish between hypertensive emergency and urgency?

EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries

Hypertensive emergency is characterized by acute hypertension-mediated organ damage but also a life-threatening status

Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk

Beta blocker rebound phenomenon is important, but we do not know its definition, incidence or optimal prevention strategies

Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions

Impending hypertensive emergency is frequently considered in guidelines, but neither defined nor explained

Long-lasting, resistant hypertension should be a part of the aortic dissection risk score

Diabetic Cardiomyopathy: Clinical and Metabolic Approach

Compelling Indications Should be Listed for Individual Beta-Blockers (Due to Diversity), Not for the Whole Class

Contraindications Differ Widely Among Beta Blockers and Ought to be Cited for an Individual Drug, Not for the Entire Class

Coronary Microvascular Dysfunction and Hypertension: A Bond More Important than We Think

The Mechanisms of Actions of Aldosterone and its Antagonists in Cardiovascular Disease

Electrocardiographic criteria which have the best prognostic significance in hypertensive patients with echocardiographic hypertrophy of left ventricle: 15‐year prospective study

Rationale to search for masked hypertension in severe Cushing's disease

A Critical Approach of Guideline Therapeutic Recommendations for NAFLD

Cardiac Magnetic Resonance in Hypertensive Heart Disease: Time for a New Chapter

Exercise Capacity and Atrial Fibrillation Risk in Veterans

Conservative versus aggressive blood pressure reduction: Do we have a winner?

Non-pharmacological Modulation of the Autonomic Nervous System for Heart Failure Treatment: Where do We Stand?

Sodium-glucose Cotransporter 2 Inhibitors: Potential Cardiovascular and Mortality Benefits

Dihydropyridine calcium channel blocker should be mentioned for prevention of aortic consequences of arterial hypertension

The pathophysiological basis of carotid baroreceptor stimulation for the treatment of resistant hypertension

Significance of Beta-Blocker in Patients with Hypertensive Left Ventricular Hypertrophy and Myocardial Ischemia

Early Left Ventricular Systolic and Diastolic Dysfunction in Patients with Newly Diagnosed Obstructive Sleep Apnoea and Normal Left Ventricular Ejection Fraction

Suchergebnisse filtern